Shiraki M, Chen J T, Kanda N, Hosoda K
Research Institute and Practice for Involutional Diseases, Keio University.
Nihon Rinsho. 1994 Sep;52(9):2268-74.
Bone formation and bone resorption are altered in most metabolic bone diseases. Recent advances in measurement of bone metabolic markers arrows as the non-invasive investigation of bone metabolic balance. The rate of formation or degradation of the bone matrix can be assessed by the measurement of bone specific proteins and it's degradative products. Among the posturated products, osteocalcin, carboxy-terminal propeptide of type I collagen (PICP) are considered to be more specific indices to know the osteoplastic function. On the other hand, pyridinoline or deoxypyridinoline in urine strongly reflects bone resorption rate. However some criticisms still exist in the evaluation of serum or urinary levels of bone metabolic markers, especially in formation markers. In adults, bone formation marker such as osteocalcin negatively correlated with their bone mineral density. On the other hand, in children, osteocalcin positively correlated with height velocity. Therefore we have to pay special attention to dysfunction of osteoblast, such as retarded calcification in evaluation of serum level of bone formation markers.
在大多数代谢性骨病中,骨形成和骨吸收都会发生改变。骨代谢标志物测量方面的最新进展为骨代谢平衡的非侵入性研究指明了方向。骨基质的形成或降解速率可通过测量骨特异性蛋白及其降解产物来评估。在这些产物中,骨钙素、I型胶原羧基末端前肽(PICP)被认为是了解成骨功能更具特异性的指标。另一方面,尿液中的吡啶啉或脱氧吡啶啉能强烈反映骨吸收速率。然而,在评估骨代谢标志物的血清或尿液水平时,尤其是在形成标志物方面,仍存在一些批评意见。在成年人中,骨钙素等骨形成标志物与其骨密度呈负相关。另一方面,在儿童中,骨钙素与身高增长速度呈正相关。因此,在评估骨形成标志物的血清水平时,我们必须特别关注成骨细胞功能障碍,如钙化延迟。